Omron Healthcare has announced that cumulative worldwide sales of Omron blood pressure monitors (BPMs) have exceeded 400 million units.
This underscores the company’s longstanding commitment to extending healthy life expectancy by advancing home blood pressure monitoring and preventive cardiovascular care, a press release to mark the milestone states.
The first Omron-branded BPM launched in 1973, when all blood pressure measurement was conducted at medical facilities. Nowadays, thanks to advances in technology, anyone can easily and accurately measure their own blood pressure at home, and Omron Healthcare has continued to drive the evolution of blood pressure management to support preventive healthcare, including efforts to detect potentially life-threatening conditions such as atrial fibrillation (AF) at an early stage.
“Reaching 400 million units sold is more than a number—it represents the trust that millions of people place in Omron Healthcare to support their journey toward longer, healthier lives,” said Ayumu Okada, president and chief executive officer, Omron Healthcare.
“The quality and accuracy of Omron blood pressure monitors are well recognised by healthcare professionals around the world. We remain dedicated to ‘Going for ZERO’ vision, aiming to eradicate cerebro-cardiovascular events globally by developing technologies that connect daily life and healthcare, empowering people everywhere to take preventive action. We will continue to promote innovative products, services, and educational efforts to raise awareness of hypertension risks—not only for those already diagnosed, but also for those who may not yet realise they are at risk.”
